The Local Injection of Peritoneal Macrophages Induces Neovascularization in Rat Ischemic Hind Limb Muscles

Macrophages play a pivotal role in the development of newly formed vascular networks, in addition to their normal immunological functions. This research focuses on peritoneal macrophages as a novel source in cell implantation therapy for ischemic diseases. In this study, production of angiogenic growth factors by peritoneal macrophages and its in vivo effect of neovascularization were evaluated. Mononuclear cells from the peritoneal cavity (P-MNCs) enriched with macrophages were isolated and stimulated with hypoxia and interleukin-1β (IL-1β) to mimic an ischemic tissue environment in vitro. Expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) of mRNA in P-MNCs was apparently enhanced by hypoxic stimulation, and the production of VEGF protein was also augmented by hypoxia and IL-1β. A rat ischemic hind limb model was created and P-MNCs (8 × 106/limb) were injected into the ischemic muscles. The blood flow, which was assessed using the colored microsphere method, showed that the percentage blood flow was significantly increased by P-MNCs injection 4 weeks after surgery (48.3 ± 16.8% in noninjected ischemic limb vs. 84.3 ± 13.0% in the P-MNCs-injected limb). A histological analysis revealed that the number of capillaries detected by alkaline phosphatase staining was increased in the P-MNCs group 4 weeks after injection. Furthermore, the number of α-smooth muscle actin-positive vessels also showed a significant increase following P-MNC injection. The injected P-MNCs labeled with fluorescence were detected in the interstitial space of ischemic muscles, and VEGF protein expression of the implanted cells was confirmed by immunohistochemistry. These results indicate that peritoneal macrophages stimulate capillary formation and arteriogenesis in the ischemic limbs, possibly through the production of angiogenic growth factors. These findings suggest that the physiological angiogenic property of peritoneal macrophages could therefore be utilized for neovascularization in cell implantation therapy.

[1]  A. Ziada,et al.  The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. , 1984, Cardiovascular research.

[2]  E. Döpp,et al.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Advances in experimental medicine and biology.

[3]  J. Neefjes,et al.  Heterogeneity of Macrophages in the Rat Evidenced by Variability in Determinants: Two New Anti‐Rat Macrophage Antibodies Against a Heterodimer of 160 and 95 kd (CD11/CD18) , 1989, Journal of leukocyte biology.

[4]  G. Heusch,et al.  Measurement of Regional Myocardial Blood Flow With Multiple Colored Microspheres* , 1991, Circulation.

[5]  A. El-Husseini,et al.  Basic fibroblast growth factor (BFGF) and two of its receptors, FGFR1 and FGFR2: gene expression in the rat brain during postnatal development as determined by quantitative RT-PCR , 1994, Molecular and Cellular Endocrinology.

[6]  D. Charnock-Jones,et al.  Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. , 1996, The Journal of clinical investigation.

[7]  N. Chegini.  The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). , 1997, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[8]  S. Leibovich,et al.  Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. , 1998, The American journal of pathology.

[9]  W. Schaper,et al.  Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. , 1998, The Journal of clinical investigation.

[10]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[11]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[12]  M. Burdick,et al.  MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. , 1998, The Journal of clinical investigation.

[13]  J. Isner,et al.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.

[14]  G. Bonsignore,et al.  Phenotypic and functional characterization of normal rat pleural macrophages in comparison with autologous peritoneal and alveolar macrophages. , 1999, American journal of respiratory cell and molecular biology.

[15]  B. Berse,et al.  Hypoxia augments cytokine (transforming growth factor‐beta (TGF‐β) and IL‐1)‐induced vascular endothelial growth factor secretion by human synovial fibroblasts , 1999, Clinical and experimental immunology.

[16]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[17]  S. Shapiro,et al.  Contribution of Monocytes/Macrophages to Compensatory Neovascularization: The Drilling of Metalloelastase-Positive Tunnels in Ischemic Myocardium , 2000, Circulation research.

[18]  J. Mclaren.  Vascular endothelial growth factor and endometriotic angiogenesis. , 2000, Human reproduction update.

[19]  K. Hamano,et al.  The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. , 2001, Surgery.

[20]  M. Goebeler,et al.  Chemokines in cutaneous wound healing , 2001, Journal of leukocyte biology.

[21]  M. Matsuzaki,et al.  Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. , 2001, Japanese circulation journal.

[22]  H. A. Hartman,et al.  Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. , 2001, Cardiovascular research.

[23]  T. Maciag,et al.  The putative convergent and divergent natures of angiogenesis and arteriogenesis. , 2001, Circulation research.

[24]  A. Templeton,et al.  Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. , 2002, Reproduction.

[25]  R. Lederman,et al.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial , 2002, The Lancet.

[26]  Tao-Sheng Li,et al.  Neovascularization Induced by Autologous Bone Marrow Cell Implantation in Peripheral Arterial Disease , 2002, Cell transplantation.

[27]  T. Henry,et al.  Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.

[28]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[29]  Y. Mori,et al.  Angiogenesis by Implantation of Peripheral Blood Mononuclear Cells and Platelets Into Ischemic Limbs , 2002, Circulation.

[30]  N. Moldovan,et al.  Migration of monocytes/macrophages in vitro and in vivo is accompanied by MMP12-dependent tunnel formation and by neovascularization. , 2002, Cold Spring Harbor symposia on quantitative biology.

[31]  Tao-Sheng Li,et al.  Angiogenesis induced by the injection of peripheral leukocytes and platelets. , 2002, The Journal of surgical research.

[32]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[33]  W. Schaper,et al.  Factors Regulating Arteriogenesis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[34]  C. Lewis,et al.  Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. , 2003, The American journal of pathology.

[35]  E. Wahlberg.  Angiogenesis and arteriogenesis in limb ischemia. , 2003, Journal of vascular surgery.

[36]  Sunyoung Kim,et al.  Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease , 2004, Experimental & Molecular Medicine.

[37]  M. Aoki,et al.  Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease , 2004, Hypertension.

[38]  M. Hartnett,et al.  VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. , 2004, Molecular vision.

[39]  H. Matsubara,et al.  Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. , 2004, Journal of molecular and cellular cardiology.

[40]  Y. Mori,et al.  Mechanism for IL-1β-mediated Neovascularization Unmasked by IL-1βKnock-out Mice(Molecular Biology, Vascular 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2004 .

[41]  T. Meinertz,et al.  Tissue Resident Cells Play a Dominant Role in Arteriogenesis and Concomitant Macrophage Accumulation , 2004, Circulation research.

[42]  N. K. Popova,et al.  Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an external standard , 2005, Journal of Neuroscience Methods.

[43]  F. Sohrabji,et al.  The neurotrophin receptor p75NTR mediates early anti-inflammatory effects of estrogen in the forebrain of young adult rats , 2005, BMC Neuroscience.

[44]  Rong A. Wang,et al.  The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia. , 2005, Journal of vascular surgery.